Extension Study to Evaluate the Safety and Efficacy of Luspatercept in Participants With β-Thalassemia Previously Enrolled in A536-04 (A536-06/MK-6143-004)

计划入组 51 人 · 首次发布于 2014 年 10 月 20 日

Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia

计划入组 40 人 · 首次发布于 2022 年 8 月 9 日

EKLF Gene Expression in β-thalassemia

计划入组 150 人 · 首次发布于 2024 年 6 月 4 日

β-thalassemia(Orna)

thalassemia therapeutics

Betibeglogene autotemcel(Zynteglo)

Gene Therapy Shows Promise in Treating Severe β-Thalassemia

UK Approves World's First CRISPR Gene Therapy for Sickle Cell Disease and β-Thalassemia

YolTech Therapeutics Launches Clinical Trial for In Vivo Gene Editing Therapy YOLT-204 in Transfusion-Dependent Beta-Thalassemia